Latest Monadnocks Stories
PLAINS, Pa., Oct. 10, 2012 /PRNewswire/ -- The Huntzinger Management Group, Inc. (HMG), a leader in healthcare advisory and managed services consulting, has successfully facilitated the implementation of Cerner Millennium EMR at Mt. Ascutney Hospital and Health Center in Windsor, VT. HMG managed the project, which came to fruition in September, 2012. "Without HMG, we would not have been able to go live when we did, nor would we have been as effective or efficient in such a...
ADDISON, Texas, Aug. 8, 2012 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the second quarter ended June 30, 2012 financial results and to provide a general business update on Wednesday, August 15, 2012 at 9:00 a.m. Eastern Time. To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 23885#) five to ten minutes prior to the initiation of the...
ADDISON, Texas, May 10, 2012 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR)today announced that it has scheduled a conference call to discuss the first quarter ended March 31, 2012 financial results and to provide a general business update on Wednesday, May 16, 2012 at 9:00 a.m. Eastern Time. To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 23869#) five to ten minutes prior to the initiation of the...
ADDISON, Texas, March 22, 2012 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU) today announced that it has scheduled a conference call to discuss the fourth quarter and year ended December 31, 2011 financial results and to provide a general business update on Monday, April 2, 2012 at 9:00 a.m. Eastern Time. To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 23854#) five to ten minutes prior to the initiation of the...
ADDISON, Texas, March 20, 2012 /PRNewswire/ -- ULURU Inc. (NYSE Amex: ULU), announced today that Altrazeal®( )has been approved for marketing in New Zealand. Commenting on the approval in New Zealand, Kerry P. Gray, President and CEO of ULURU, stated, "The approval for New Zealand is very timely as the Australian Wound Management Association Conference is currently being held in Sydney. At this conference key opinion leaders from both Australia and New Zealand are being...
ADDISON, Texas, Jan. 17, 2012 /PRNewswire/ --ULURU Inc. (NYSE AMEX: ULU), announced today that it has extended the previously announced European license for Altrazeal® to include the Middle East and North Africa. Commenting on the extension of the territory, Helmut Kerschbaumer Chairman of Melmed Holdings AG, stated, "This is a territory where Melmed Holdings AG has experience marketing to the various sectors in these markets. We have an extensive network of marketing...
ADDISON, Texas, Jan. 17, 2012 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU), announced today that the License Agreement with Melmed Holdings AG for the marketing of Altrazeal®( )in Europe, Australia, New Zealand, the Middle East and Northern Africa has been finalized. Under the terms of the License Agreement, ULURU has licensed the rights for the marketing of Altrazeal® to Melmed Holdings AG, who are establishing a separate entity to market Altrazeal®, in Europe, Australia, New...
ADDISON, Texas, Nov. 11, 2011 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU) today announced that it has scheduled a conference call to discuss the third quarter ended September 30, 2011 financial results and to provide a general business update on Tuesday, November 15, 2011 at 9:00 a.m. Eastern Time. To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 23823#) five to ten minutes prior to the initiation of the...
ADDISON, Texas, Oct. 13, 2011 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU), announced today that it has signed a binding letter of intent with Melmed Holdings AG, a company based in Switzerland, to license Altrazeal® for the European Union. Under the terms of the agreement ULURU will license the European Union rights to a subsidiary of Melmed Holdings AG specifically formed to market Altrazeal® in the European Union. In exchange for the license ULURU will receive a licensing payment...
ADDISON, Texas, Aug. 11, 2011 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU) today announced that it has scheduled a conference call to discuss the second quarter ended June 30, 2011 financial results and to provide a general business update on Tuesday, August 16, 2011 at 9:00 a.m. Eastern Time. To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 23818#) five to ten minutes prior to the initiation of the teleconference....
